ScholarIQanswers from OpenAlex

Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy

PaperCitations, authors & open-access status

Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy have?

ScholarIQcitation count

Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy has 368 citations in the OpenAlex counts ScholarIQ stores.

When was Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy published?

ScholarIQyear

Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy has 2011 year in the ScholarIQ index.

What is the open-access status of Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy?

ScholarIQoa status

Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy has bronze oa status in the ScholarIQ index.

What is the DOI of Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy?

ScholarIQdoi

The DOI for Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy is on the source record.

What is the PMID of Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy?

ScholarIQpmid

The PMID for Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy is on the source record.

What is the OpenAlex record for Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy?

ScholarIQopenalex

The OpenAlex for Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial